论文部分内容阅读
在治疗癌症时,药物往往产生副作用。最近日本协和发酵工业会社研制了既能克服癌症治疗中引起的副作用,并有抗癌作用的新药G-CSF(人类颗粒球刺激基因)。在癌症治疗中,最大副作用是白血球(颗粒球是其之一)减少以及伴随而来的身体防御机能的下降。G-CSF本来就是人体内的物质,具有增加颗粒球的作用。该社通过遗传基因更新技术,将其一部予以修饰,制备了“KW2228”,现正进行动物及临床试验。将患有恶性癌黑素瘤的鼠分成甲、乙两组。对甲组每日喂予G-CSF10d,乙组则不喂。结果乙组鼠平
In the treatment of cancer, drugs often have side effects. Recently, Kyowa Hakko Kogyo Co., Ltd. developed a new drug, G-CSF (Human Particle Stimulation Gene), that can overcome the side effects caused by cancer therapy and has an anti-cancer effect. In cancer therapy, the biggest side effect is the reduction of white blood cells (one of the particle spheres) and the consequent decrease in body defenses. G-CSF has always been the substance of the human body, with the role of increasing the particle ball. The agency through the genetic modification technology, will be part of its modification, prepared “KW2228”, is now conducting animal and clinical trials. Rats with malignant melanoma were divided into two groups. Group A daily G-CSF10d, B is not fed. Results group B rat flat